Biogen Presents Optimistic Outcomes from Section 2 IGNAZ Examine of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024 By Investing.com
The detailed examine outcomes confirmed interim findings, exhibiting secure kidney perform and…
Mallinckrodt Presents Information on TERLIVAZ ® (terlipressin) for Injection in Sufferers with Hepatorenal Syndrome (HRS) at Kidney Week 2024 By Investing.com
“ Pooled evaluation from Part 3 scientific trials highlights liver transplant charges…
Travere Therapeutics Presents Knowledge Reinforcing Scientific Advantage of FILSPARI ® (Sparsentan) in IgAN and Late-Breaking Presentation in FSGS at ASN Kidney Week 2024 By Investing.com
Practically 60% of sufferers with IgAN within the SPARTAN Research achieved full…
